Eclusive PCCA Bases Quick-Reference Poster | © PCCA 2019See PCCA Document #99650 for a short booklet highlighting PCCA’s most popular bases.

PCCA Exclusive Base Dosage Form(s) Ideal in Formulations For Common APIs Example Formulas

Atrevis™ HydrogelPCCA #30-4986

• Superior testosterone delivery backed up by independent testing

• Alcohol-free for better stability and less irritation

• Quick absorption, smooth texture, and no greasy residue

Topical gel Testosterone replacement Testosterone

• PCCA Formula #12674 Testosterone 0.5% to 20% (Bracketed)

• PCCA Formula #12676 Testosterone 5%/Anastrozole 0.05%/HCG 500 U/Gm

• PCCA Formula #12681 Testosterone 5%/Finasteride 0.1%

Clarifying Base™

PCCA #30-4845

• Topical base that moisturizes and supports healthy skin

• May improve the appearance of red, blotchy skin

• Easily accommodates antimicrobials, benzoyl peroxide, tretinoin, alpha and beta hydroxy acids, and more

Topical cream

• Acne/problem skin

• Rosacea

• Aging skin prone to acne

• Benzoyl peroxide

• Salicylic acid

• Tretinoin

• Erythromycin

• PCCA Formula #11800 Clindamycin 1%/Benzoyl Peroxide 5%/Superoxide Dismutase 0.5%/Vitamin D3 0.5%

• PCCA Formula #11710 Niacinamide 5%/Glycosaminoglycans 5%/Dimethyl Sulfone 2%/Biotin 0.2%

• PCCA Formula #11713 Sodium Hyaluronate 0.05%/Collagen/Aloe Vera/Glycolic Acid/Vitamin E

Lipoderm®

PCCA #30-3338

• Validated vehicle for deep-penetrating topical formulations and transdermal formulations

• Patented transdermal technology backed by numerous peer-reviewed studies

• Over 15 formulas with extended beyond-use datesTransdermal cream

• Acute or chronic pain

• Anxiety

• Nausea

• Veterinary medicine

• Analgesics and anesthetics

• Anxiolytics

• Antiemetics

• PCCA Formula #10835 Ketamine HCl 5%/Gabapentin 10%/Clonidine HCl 0.2%/ Baclofen 2%

• PCCA Formula #12375 Promethazine HCl 12.5 mg/Gm to 25 mg/Gm Topical (Bracketed)

• PCCA Formula #12373 Methimazole 2.5 mg/0.1 Gm to 10 mg/0.1 Gm (Bracketed)

Lipoderm ActiveMax®

PCCA #30-4482

• Developed for APIs in salt form at high concentrations

• Uses the same patented transdermal system as Lipoderm

• Eight formulas with extended beyond-use dates

APIs that are in a salt form (e.g., Cl, Na)

• PCCA Formula #10287 Diclofenac Sodium 5%/Gabapentin 5%/Amitriptyline HCl 2%

• PCCA Formula #11090 Flurbiprofen 10%/Baclofen 2%/Cyclobenzaprine HCl 2%/Tetracaine 2%

• PCCA Formula #10673 Clomiphene Citrate 5%

LoxaSperse®

PCCA #30-4701

• Powder base that provides topical delivery to the nasal and sinus cavities when reconstituted

• Reduces particle size and increases dispersibility and solubility of APIs

• Easy to store and carry with prolonged beyond-use date in powder/capsule preparation

• Commonly compounded with PCCA XyliFos® (PCCA #30-4894)

Nasal nebulization and irrigation Chronic sinus conditions

• Antifungals

• Antibiotics

• Corticosteroids

• PCCA Formula #12850 Mupirocin 5 mg/Budesonide 0.6 mg Capsules Size #1

• PCCA Formula #12855 Tobramycin 20 mg/Budesonide 0.6 mg Capsules Size #1

• PCCA Formula #12857 Clindamycin 30 mg/Budesonide 0.6 mg Capsules Size #1

LoxOral®PCCA #30-4774

• Powder base that makes capsules easier to prepare and saves time

• Reduces static, making micronized powders easier to work with

• Provides even distribution and improved dissolution of APIs

Oral capsules

• Oral hormone replacement therapy (HRT)

• General systemic medication

• Veterinary medicine

• Progesterone

• Estriol

• Estradiol

• PCCA Formula #11296 Estriol/Estradiol [80%/20%] 2 mg/Progesterone 100 mg/Testosterone 0.5 mg/DHEA 25 mg Slow Release Capsules Size #0

• PCCA Formula #10797 Progesterone 100 mg Slow Release Capsules Size #1

• PCCA Formula #10805 Naltrexone HCl 0.5 mg Capsules Size #1

MucoLox™

PCCA #30-4782

• Unique liquid-gel base that adheres to mucosa up to 24 times longer than other products

• Increases contact time between APIs and mucosa

• Can be diluted with water to adjust viscosity

• Commonly compounded with VersaBase® Gel (PCCA #30-3656) to create vaginal gels

• Oral, vaginal or rectal gel

• Oral mouthwash or spray

• Esophageal/gut suspension

• Vaginal HRT

• Oral mucositis

• Proctitis

• Hormones

• Anesthetics

• Corticosteroids

• PCCA Formula #11115 Estriol 0.05% Vaginal Gel

• PCCA Formula #12066 Stanford Modified Oral Rinse (Lab Study)

• PCCA Formula # 12228 Budesonide 1 mg/10 mL to 2 mg/10 mL Oral Suspension

(Bracketed)

PracaSil®-PlusPCCA #30-4655

• Anhydrous topical silicone base that provides superior moisturization and protection

• Contains pracaxi oil that is rich in skin-friendly fatty acids and lipids

• Promotes a soothing and nurturing environment

Topical gel

• All scars, including new, old, keloid, hypertrophic and surgical

• Burns and diabetic wounds

• Stretch marks

• Corticosteroids and antioxidants

• Anesthetics and NSAIDs

• Antibiotics and antifungals

• PCCA Formula #10826 Fluocinolone Acetonide 0.01%/Hydroquinone 4%/Tretinoin 0.05%

• PCCA Formula #10419 Tretinoin 0.1%

• PCCA Formula #10234 Tamoxifen Citrate 0.1%/Tranilast 1%/Caffeine Citrated 0.1%/Lipoic Acid 0.5%

SuspendIt®

PCCA #30-4825

• Oral-suspension base that thins when shaken and thickens when standing

• Minimizes sedimentation and allows for rapid redispersion of APIs with agitation

• All-natural sweetness derived from monk fruit

Oral suspension

• Pediatric compounding

• Hospice and oncology

• Veterinary medicine

• Proton-pump inhibitors

• Corticosteroids

• Anticonvulsants

• PCCA Formula #11262 Omeprazole 2 mg/mL to 10 mg/mL (Bracketed)

• PCCA Formula #12539 Phenobarbital 1 mg/mL to 50 mg/mL (Bracketed)

• PCCA Formula #5374 Cisapride 10 mg/mL (Vet)

VersaBase® CreamPCCA #30-3641

• Elegant yet durable topical cream that is stable over a broad pH range (3.5-12)

• Noncomedogenic, hypoallergenic, nonirritating and odor-free

• Formulated without oil, petrolatum, parabens and propylene glycol

• Topical cream

• Vaginal cream

• Hormone Replacement Therapy (HRT)

• General topical compounding

• Estriol

• Estradiol

• Progesterone

• PCCA Formula #12116 Estriol/Estradiol [50%/50%] 0.25 mg/0.5 Gm to 1 mg/0.5 Gm Topical Cream (Bracketed)

• PCCA Formula #12114 Progesterone 10 mg/Gm to 100 mg/Gm Topical Cream (Bracketed)

• PCCA Formula #12227 Amitriptyline HCl 0.25% to 5% Vaginal Cream (Bracketed)

XemaTop™

PCCA #30-4891

• Topical base containing a skin-friendly blend of boswellic acid, avenanthramides from oats, phosphatidylglycerol and film formers

• Moisturizes while nourishing the skin’s structural integrity

• May improve the appearance of red, irritated, flaky skin

Topical cream

• Eczema

• Psoriasis

• Xerosis (dry skin)

• Corticosteroids

• Vitamins B, D and E, and derivatives

• Zinc pyrithione

• PCCA Formula #12371 Cyanocobalamin 0.07% to 1% (Bracketed)

• PCCA Formula #12374 Pentoxifylline 5% to 15% (Bracketed)

• PCCA Formula #11788 Zinc Pyrithione 0.2%/Clobetasol Propionate 0.05%/Cyanocobalamin 0.07%

= FormulaPlus™ BUD StudyExclusive PCCA Bases Quick-Reference Poster | For studies on these bases, visit pccarx.com/science.